Endometrial Cancer Detection During the Coronavirus Disease 2019 (COVID-19) Pandemic

Obstet Gynecol. 2020 Oct;136(4):842-843. doi: 10.1097/AOG.0000000000004087.

Abstract

During the first 12 weeks of the coronavirus disease 2019 (COVID-19) pandemic, endometrial cancer diagnoses declined 35% and patient calls for abnormal bleeding declined 33% compared with 2019 levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Betacoronavirus
  • COVID-19
  • Communicable Disease Control
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / psychology
  • Delayed Diagnosis / prevention & control*
  • Early Detection of Cancer / standards*
  • Endometrial Neoplasms* / epidemiology
  • Endometrial Neoplasms* / pathology
  • Endometrial Neoplasms* / physiopathology
  • Fear
  • Female
  • Humans
  • Incidence
  • Insurance Claim Review / statistics & numerical data
  • Needs Assessment
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / psychology
  • Remote Consultation / statistics & numerical data
  • SARS-CoV-2
  • Time-to-Treatment / standards
  • United States / epidemiology
  • Uterine Hemorrhage* / diagnosis
  • Uterine Hemorrhage* / epidemiology
  • Uterine Hemorrhage* / etiology